Home   >  
PI3K/Akt/mTOR
  >  
PI3K

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

PI3K

Chemical Structure Cat. No. Product Name CAS No.
SRX3177 Chemical Structure
BCP48567 SRX3177 2241237-51-2
SRX3177 is a novel potent triple action inhibitor, targeting BRD, PI3K, and CDK.
PI3K/mTOR Inhibitor-2 Chemical Structure
BCP48401 PI3K/mTOR Inhibitor-2 1848242-58-9
PI3K/mTOR Inhibitor-2 is a potent dual pan-PI3K/mTOR inhibitor.
AZD-3458 Chemical Structure
BCP47242 AZD-3458 2132961-46-5
AZD3458 is a potent and remarkably selective PI3Kγ inhibitor for PI3Kγ, PI3Kα, PI3Kβ, and PI3Kδ.
Disitertide Chemical Structure
BCP46789 Disitertide 272105-42-7
Disitertide is a peptidic transforming growth factor-beta 1 (TGF-β1) inhibitor specifically designed to block the interaction with its receptor. Disitertide is also a PI3K inhibitor and an apoptosis inducer.
IHMT-PI3Kδ-372 Chemical Structure
BCP46775 IHMT-PI3Kδ-372 2429889-62-1
IHMT-PI3Kδ-372 is a potent and selective phosphatidylinositol 3-kinase δ (PI3Kδ) inhibitor with an IC50 of 14 nM in the biochemical assay.
Gilmelisib Chemical Structure
BCP46378 Gilmelisib 1845777-61-8
Gilmelisib is a PI3K inhibitor and antineoplastic.
GSK251 Chemical Structure
BCP46226 GSK251 2125968-05-8
GSK251 is a highly potent, highly selective, orally bioavailable inhibitor of PI3Kδ with a novel binding mode.
ETP-45658 Chemical Structure
BCP45165 ETP-45658 1198357-79-7
ETP-45658 is a PI3-kinase inhibitor, also ihibiting DNA-PK and mTOR.
GS-9901 Chemical Structure
BCP44115 GS-9901 1640247-87-5
GS-9901 is a potent, orally active and highly selective inhibitor of PI3Kδ (PI3Kdelta IC50 = 1.0nM, HWB delta EC50 = 1.5 nM; CLpr hHep = 0.05 L/h/kg.).
Panulisib Chemical Structure
BCP44105 Panulisib 1356033-60-7
Panulisib is an orally bioavailable inhibitor of phosphoinositide 3-kinase (PI3K), mammalian target of rapamycin (mTOR), activin receptor-like kinase 1 (ALK-1) and DNA-dependent protein kinase (DNA-PK), with potential anti-angiogenic and antineoplastic activities.
123下一页末页共 143 条记录 1 / 15 页 
0086-13720134139